Comments
Drug firm Lupin on Wednesday said inspection by the US health regulator of its bioresearch centre in Pune has been completed without any observations.
“This is the fifth successive inspection without any 483 observations, indicating superior quality compliance maintained at this global bioresearch facility,” Lupin said in a statement. The inspection of Lupin Bioresearch Centre by the United States Food and Drug Administration (USFDA) has been successfully completed without any observations, it added.
Commenting on the development, Lupin MD Nilesh Gupta said: “Such a high level of compliance reiterates Lupin’s commitment to high-quality standards across its world class research centres.” The centre conducts the in-vivo and in-vitro bioequivalence studies in Pune. This inspection also included review of studies done at its new site at Lupin Research Park, Pune, the statement said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.